In summary, the abnormal activation of the PI3K/AKT/mTOR signalling pathway and the dysfunction of PIKK members in DNA damage repair are closely related to the occurrence of cancer and drug resistance during treatment. The gene discussed is PIK3CG; the disease is cancer.